168 related articles for article (PubMed ID: 22431275)
1. Elevated gastrin-releasing peptide receptor mRNA expression in buccal mucosa: association with head and neck squamous cell carcinoma.
Egloff AM; Liu X; Davis AL; Trevelline BK; Vuga M; Siegfried JM; Grandis JR
Head Neck; 2013 Feb; 35(2):270-9. PubMed ID: 22431275
[TBL] [Abstract][Full Text] [Related]
2. Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the head and neck.
Lango MN; Dyer KF; Lui VW; Gooding WE; Gubish C; Siegfried JM; Grandis JR
J Natl Cancer Inst; 2002 Mar; 94(5):375-83. PubMed ID: 11880476
[TBL] [Abstract][Full Text] [Related]
3. L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.
Geomela PA; Kontos CK; Yiotakis I; Fragoulis EG; Scorilas A
BMC Cancer; 2012 Oct; 12():484. PubMed ID: 23083099
[TBL] [Abstract][Full Text] [Related]
4. Association of drug transporter expression with mortality and progression-free survival in stage IV head and neck squamous cell carcinoma.
Warta R; Theile D; Mogler C; Herpel E; Grabe N; Lahrmann B; Plinkert PK; Herold-Mende C; Weiss J; Dyckhoff G
PLoS One; 2014; 9(9):e108908. PubMed ID: 25275603
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of glycerol-3-phosphate dehydrogenase 1-like expression in head and neck squamous cell carcinoma.
Feng Z; Li JN; Wang L; Pu YF; Wang Y; Guo CB
Histopathology; 2014 Feb; 64(3):348-55. PubMed ID: 24274692
[TBL] [Abstract][Full Text] [Related]
6. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
Geomela PA; Kontos CK; Yiotakis I; Scorilas A
J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
[TBL] [Abstract][Full Text] [Related]
7. Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck.
Thurfjell N; Coates PJ; Boldrup L; Lindgren B; Bäcklund B; Uusitalo T; Mahani D; Dabelsteen E; Dahlqvist A; Sjöström B; Roos G; Vojtesek B; Nenutil R; Nylander K
Adv Otorhinolaryngol; 2005; 62():49-57. PubMed ID: 15608417
[TBL] [Abstract][Full Text] [Related]
8. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.
Wu ES; Park JY; Zeitouni JA; Gomez CR; Reis IM; Zhao W; Kwon D; Lee E; Nelson OL; Lin HY; Franzmann EJ; Savell J; McCaffrey TV; Goodwin WJ; Hu JJ
Head Neck; 2016 Aug; 38(8):1234-41. PubMed ID: 27028310
[TBL] [Abstract][Full Text] [Related]
9. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
[TBL] [Abstract][Full Text] [Related]
11.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
12. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
[TBL] [Abstract][Full Text] [Related]
13. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
[TBL] [Abstract][Full Text] [Related]
14. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
Chan G; Boyle JO; Yang EK; Zhang F; Sacks PG; Shah JP; Edelstein D; Soslow RA; Koki AT; Woerner BM; Masferrer JL; Dannenberg AJ
Cancer Res; 1999 Mar; 59(5):991-4. PubMed ID: 10070952
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
18. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.
Childs G; Fazzari M; Kung G; Kawachi N; Brandwein-Gensler M; McLemore M; Chen Q; Burk RD; Smith RV; Prystowsky MB; Belbin TJ; Schlecht NF
Am J Pathol; 2009 Mar; 174(3):736-45. PubMed ID: 19179615
[TBL] [Abstract][Full Text] [Related]
19. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
20. A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell Carcinoma.
Qiang H; Zhan X; Wang W; Cheng Z; Ma S; Jiang C
Cancer Biother Radiopharm; 2019 Apr; 34(3):189-195. PubMed ID: 30628842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
